Form 8-K - Current report:
SEC Accession No. 0000950170-24-108493
Filing Date
2024-09-20
Accepted
2024-09-20 17:25:48
Documents
12
Period of Report
2024-09-20
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hcwb-20240920.htm   iXBRL 8-K 47516
2 EX-16.1 hcwb-ex16_1.htm EX-16.1 6875
  Complete submission text file 0000950170-24-108493.txt   170984

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hcwb-20240920.xsd EX-101.SCH 24848
14 EXTRACTED XBRL INSTANCE DOCUMENT hcwb-20240920_htm.xml XML 4700
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

EIN.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40591 | Film No.: 241314211
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)